Cite
MLA Citation
Kamyar Kalantar-Zadeh et al.. “FP330APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS.” Nephrology dialysis transplantation, vol. 34, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100092364015.0x000024